Clinical trial
Safety Study of XP12B in Women With Menorrhagia
NCT00113568 · Ferring Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00113568 |
|---|---|
| Title | Safety Study of XP12B in Women With Menorrhagia |
| Official title | Multicenter Study to Evaluate the Safety of XP12B in Women With Heavy Menstrual Bleeding Associated With Menorrhagia |
| Lead sponsor | Ferring Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Menorrhagia, Heavy Menstrual Bleeding |
| Intervention type | Drug |
| Interventions | Tranexamic acid tablets (XP12B) |
| Enrollment | 784 |
| Start date | Jun 1, 2005 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Jun 9, 2005 |
| Last update posted | Jun 15, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: